Narrow Your Search

Narrow Your Search

Focus

Companies

People

News

11,610 News Articles
May
14
2025

Natural Mushroom Compound Shows Promise in Treating Parkinson's Symptoms

TEHRAN (ANA)- A pilot study by UCSF reveals unexpected results, with psilocybin therapy leading to significant improvements in mood, ...
May
14
2025

Why ketamine isn't risk-free - Ravalli Republic

Click here to view this video from http://www.ravallirepublic.com.
May
14
2025

Andhra Pradesh CM launches Bharat Biotech arm Lumpy Skin Disease vaccine

Vijayawada: Chief Minister of Andhra Pradesh Shri N. Chandrababu Naidu has launched the indigenous Lumpy Skin Disease (LSD) vaccine BIOLUMPIVAXIN, ...
May
14
2025

BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in ... - Stock Titan

The drug shows a breakthrough mechanism by selectively activating the 5HT2A receptor to 60%, staying below the 70% hallucination threshold, unlike LSD ...
May
14
2025

DeSantis says he will sign legislation banning psychedelic mushroom spores in Florida

Gov. Ron DeSantis said last week that he will soon sign legislation that, among its provisions, would ban trafficking in psychedelic mushroom ...
May
14
2025

Alar Pharmaceuticals Announces First Patient Dosing in a Study of ALA-3000 (Extended ...

... Ketamine (ALA-3000) for Treatment-Resistant Depression (TRD) in the US ... ALA-3000, developed by Alar Pharmaceuticals, is the first formulation of ...
Ketamine
May
14
2025

A Brief History of LSD Treatment for Alcohol Addiction at the VA - Filter

Characteristics of the “psychedelic renaissance” of recent years have included numerous studies indicating benefits of psychedelic drugs for ...
LSD
May
14
2025

Alar Pharmaceuticals Announces First Patient Dosing in a Study of ALA-3000 (Extended ...

... Ketamine (ALA-3000) for Treatment-Resistant Depression (TRD) in the US. This phase 1, multicenter, randomized, double-blind, placebo-controlled ...
Ketamine
May
14
2025

BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in ...

In addition, unlike LSD, psilocybin, MDMA and other such agents BETR-001 is not an activator of the 5HT2B receptor. Activation of 5HT2B has been ...
MDMA
May
13
2025

Psilocybin effectively reduces symptoms of depression, study finds

Psilocybin is a naturally occurring psychedelic compound found in shrooms, occasionally referred to as "magic mushrooms." Shrooms grow in various ...
Psilocybin
May
13
2025

atai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the ... - Stock Titan

atai Life Sciences (NASDAQ: ATAI) has initiated dosing in its Phase 2 study of EMP-01 (oral R-MDMA) for treating social anxiety disorder (SAD).
May
13
2025

Can Psychedelics Help Heal Our Relationship With the Natural World? - Atmos.earth

Like their ancestors, the Ashaninka turn to a traditional medicine that helps them hear what the Earth is saying: the plant-based, psychedelic tea ...
Psychedelics
May
13
2025

atai Life Sciences Announces First Patient Dosed in Phase 2 - GlobeNewswire

In a Phase 1 study, EMP-01 (oral R-MDMA) demonstrated a unique, dose-dependent subjective effect profile that was generally found to be more ...
May
13
2025

Psychedelics may reverse brain-immune interactions that boost fear, research suggests

A study indicates that psychedelic compounds interact with brain-immune system pathways and “fundamentally reshape” immunity responses tied to ...
May
13
2025

Psychedelics linked to religious disaffiliation—but not spiritual change—in large-scale study

Psychedelics are often described as spiritual tools—but do they change people's religious beliefs? A large new study found that while psychedelic ...
LSD Psychedelics
May
13
2025

atai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the ...

... psychedelics than to racemic MDMA - The exploratory, randomized, double-blind, placebo-controlled Phase 2 study will assess the safety ...
MDMA
May
13
2025

Psychedelic Therapy & Microdosing Info Session - San Diego Reader

This is a free, educational workshop open to anyone curious about the therapeutic potential of psychedelics. The Pivot team will present on how ...
May
13
2025

Colorado Psychedelics Safety Campaign Targets Gen Z | Westword

Before You Trip is a new psychedelics safety campaign targeting young people in Colorado, but instead of an anti-drug stance, it focuses on harm ...
Psychedelics
May
12
2025

A single dose of psilocybin might help reduce symptoms in treatment-resistant depression

... psychedelics might influence consciousness in severe brain injury patients. ... Beyond improving mood, the psychedelic treatment was linked to ...
May
12
2025

Clearmind Medicine Announces Publication of European Patent for Psychedelic-Based ... - BioSpace

(Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic ...
May
12
2025

PRISM MarketView Honors Mental Health Awareness Month with - GlobeNewswire

Psychedelics, such as psilocybin and MDMA, are showing promising results in treating mental health conditions like depression, PTSD, and anxiety.
May
12
2025

Molecular approach prolongs ketamine's antidepressant effects in mice by weeks

Researchers at Vanderbilt University identified a molecular approach to extend the antidepressant effects of ketamine in mice by applying BCI, ...
May
12
2025

Clinicians Invited To Explore Breakthroughs In Psychedelics At PS2025 - Forbes

Psychedelic Science 2025 is inviting trauma therapists and other mental health professionals to attend its upcoming conference, which is designed ...
Psychedelics Psilocybin
May
12
2025

Psychedelic Mushrooms Market to Reach US$ 3.3 Bn by 2031 at a CAGR - openPR.com

... psilocybin's therapeutic potential. According to a recent report by Persistence Market Research, the market is projected to surge from a valuation ...
May
12
2025

Portugal approves psychedelic for severe depression

Infarmed has approved public financing for the first medicine containing esketamine, a psychedelic, to be used in hospitals in adults with severe ...
May
12
2025

Different anesthetics, same result: Unconsciousness by shifting brainwave phase

Under either ketamine or dexmedetomidine general anesthesia, brain waves become shifted out of phase within a hemisphere and more into phase across ...
May
08
2025

Optimi Health Completes Largest-to-Date MDMA Export to Australia for PTSD Therapy

1000 GMP doses of MDMA now reaching patients with PTSD under Australia's Authorised Prescriber Scheme; Department of Veterans' Affairs to fund ...
MDMA
May
08
2025

Psilocybin in Serious Illness: James Downar, Ali John Zarrabi and Margaret Ross - GeriPal

In today's episode, we're taking a closer look at the current state of the science around one specific psychedelic: psilocybin. We'll discuss three ...
May
08
2025

Texas House Approves Bills To Speed Access To Psychedelic-Assisted Therapies ...

... psychedelics—specifically MDMA, psilocybin and ketamine—as a treatment PTSD, depression and other mental health disorders. Officials would also ...
May
08
2025

COMPASS Pathways plc SEC 10-Q Report - TradingView

Research and Development Focus: The company is focused on developing its investigational COMP360 psilocybin treatment, particularly for treatment- ...
May
08
2025

Optimi Health Completes Largest-to-Date MDMA Export to Australia for PTSD Therapy

n Optimi Health (OPTHF) successfully exports 1000 GMP-certified MDMA capsules to Australia for PTSD treatment. Australian Department of Veterans' ...
MDMA
May
08
2025

Using MDMA to face my trauma was healing, vivid — and a bit banal - Toronto Star

She found someone with a substance first derived from the oil of the sassafras tree: MDMA, a drug said to have potential for treating PTSD. She ...
MDMA
May
08
2025

psychedelics Archives | A Geriatrics and Palliative Care Podcast for Every Healthcare Professional

We've covered psychedelics on the podcast before—first in 2019 with Ira Byock, where we explored their potential role in medicine,…
May
08
2025

Magic mushrooms may boost mood and brain health for Parkinson's disease patients, study reveals

In the first psychedelic study tested on neurodegenerative disease patients, researchers have discovered that psilocybin therapy elicits meaningful ...
May
08
2025

Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

COMP360 psilocybin treatment in TRD (Treatment Resistant Depression). The pivotal phase 3 clinical program of COMP360 psilocybin treatment in TRD ...
May
08
2025

A dose of psilocybin stirred the brain of a barely conscious woman - MSN

A new case report published in Clinical Neurophysiology describes the first known administration of psilocybin—a psychedelic compound found in ...